BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Al-Shahwani NH, Sigalet DL. Pathophysiology, prevention, treatment, and outcomes of intestinal failure-associated liver disease. Pediatr Surg Int 2017;33:405-11. [PMID: 28028560 DOI: 10.1007/s00383-016-4042-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Rostas SE. SMOFlipid: Essentials for the Neonatal Nurse. J Perinat Neonatal Nurs 2018;32:209-11. [PMID: 30036303 DOI: 10.1097/JPN.0000000000000351] [Reference Citation Analysis]
2 El Kasmi KC, Anderson AL, Devereaux MW, Balasubramaniyan N, Suchy FJ, Orlicky DJ, Shearn CT, Sokol RJ. Interrupting tumor necrosis factor-alpha signaling prevents parenteral nutrition-associated cholestasis in mice. JPEN J Parenter Enteral Nutr 2021. [PMID: 34664730 DOI: 10.1002/jpen.2279] [Reference Citation Analysis]
3 Navaratnarajah N, Girard G, Sant’anna G, Langlois H, Sant’anna AM. The impact of a lipid injectable emulsion (SMOF) on conjugated bilirubin levels in children receiving prolonged parenteral nutrition: A large single center experience. Clinical Nutrition ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.03.036] [Reference Citation Analysis]
4 Lim J, Oschman A, Curiel K. Current status of lipid emulsions in the prevention of intestinal failure-associated liver disease. Curr Opin Organ Transplant 2019;24:188-92. [PMID: 30762667 DOI: 10.1097/MOT.0000000000000620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fundora J, Aucott SW. Intestinal Failure-Associated Liver Disease in Neonates. Neoreviews 2020;21:e591-9. [PMID: 32873652 DOI: 10.1542/neo.21-9-e591] [Reference Citation Analysis]
6 Xiao Y, Zhou K, Lu Y, Yan W, Cai W, Wang Y. Administration of antibiotics contributes to cholestasis in pediatric patients with intestinal failure via the alteration of FXR signaling. Exp Mol Med 2018;50:1-14. [PMID: 30504803 DOI: 10.1038/s12276-018-0181-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
7 Onufer EJ, Han YH, Courtney C, Steinberger A, Tecos M, Sutton S, Sescleifer A, Ou J, Sanguinetti Czepielewski R, Randolph GJ, Warner BW. Liver injury after small bowel resection is prevented in obesity-resistant 129S1/SvImJ mice. Am J Physiol Gastrointest Liver Physiol 2021;320:G907-18. [PMID: 33729834 DOI: 10.1152/ajpgi.00284.2020] [Reference Citation Analysis]
8 Feng S, Belwal T, Li L, Limwachiranon J, Liu X, Luo Z. Phytosterols and their derivatives: Potential health‐promoting uses against lipid metabolism and associated diseases, mechanism, and safety issues. Comprehensive Reviews in Food Science and Food Safety 2020;19:1243-67. [DOI: 10.1111/1541-4337.12560] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
9 Kapoor V, Malviya MN, Soll R. Lipid emulsions for parenterally fed term and late preterm infants. Cochrane Database Syst Rev 2019;6:CD013171. [PMID: 31158920 DOI: 10.1002/14651858.CD013171.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Casson C, Nguyen V, Nayak P, Channabasappa N, Berris K, Panczuk J, Bhiladvala C, Dasgupta T, Piper HG. A Comparison of Smoflipid® and Intralipid® in the Early Management of Infants with Intestinal Failure. J Pediatr Surg 2020;55:153-7. [PMID: 31672409 DOI: 10.1016/j.jpedsurg.2019.09.073] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Dickerson RN, Kumpf VJ, Bingham AL, Blackmer AB, Canada TW, Chan LN, Cogle SV, Tucker AM. Significant Published Articles for Pharmacy Nutrition Support Practice in 2017. Hosp Pharm 2018;53:239-46. [PMID: 30038443 DOI: 10.1177/0018578718779006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yu Z, Huang S, Li Y, Niu Y, Chen H, Wu J. Milk Fat Globule Membrane Alleviates Short Bowel Syndrome-Associated Liver Injury in Rats Through Inhibiting Autophagy and NLRP3 Inflammasome Activation. Front Nutr 2022;9:758762. [DOI: 10.3389/fnut.2022.758762] [Reference Citation Analysis]